{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:26:25Z","timestamp":1720535185007},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":9137,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1995]]},"DOI":"10.1093\/annonc\/6.suppl_1.s73","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:58:52Z","timestamp":1353362332000},"page":"S73-S78","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Gene therapy for lung cancer"],"prefix":"10.1016","volume":"6","author":[{"given":"P.J.","family":"Woll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.R.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0060","first-page":"7","article-title":"Cancer statistics, 1994","volume":"44","author":"Boring","year":"1994","journal-title":"CA"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2554494","article-title":"p53: A frequent target for genetic abnormalities in lung cancer","volume":"246","author":"Takahashi","year":"1989","journal-title":"Science"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0140-6736(90)90801-B","article-title":"Increased expression of mutant forms of p53 oncogene in primary lung cancer","volume":"335","author":"Iggo","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1093\/annonc\/6.suppl_1.S73_bb0075","first-page":"66","article-title":"Gene replacement strategies for the prevention and therapy of lung cancer","volume":"11","author":"Roth","year":"1994","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0080","first-page":"5","article-title":"High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus","volume":"1","author":"Zhang","year":"1994","journal-title":"Cancer Gene Ther"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0085","first-page":"1744","article-title":"Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA","volume":"51","author":"Mukhopadhyay","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/hum.1993.4.4-451","article-title":"Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype","volume":"4","author":"Zhang","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0095","first-page":"1743","article-title":"Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct","volume":"53","author":"Georges","year":"1993","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.8493530","article-title":"The basic science of gene therapy","volume":"260","author":"Mulligan","year":"1993","journal-title":"Science"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.1992.10.2.180","article-title":"The immunotherapy and gene therapy of cancer","volume":"10","author":"Rosenberg","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0110","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1073\/pnas.90.10.4645","article-title":"Immunotherapy of malignancy by in vivo gene transfer into tumors","volume":"90","author":"Plautz","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0115","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor-cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0120","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.4049\/jimmunol.152.7.3501","article-title":"Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-\u03b1","volume":"152","author":"Marincola","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1093\/annonc\/6.suppl_1.S73_bb0125","first-page":"103","article-title":"A randomised controlled trial of rHuG-CSF (lenograstim) to dose intensify cytotoxic chemotherapy in small cell lung cancer (SCLC) [Abstract]","volume":"11","author":"Woll","year":"1994","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00304766","article-title":"Intensive chemotherapy with autologous bone marrow transplantation for small cell lung cancer","volume":"24","author":"Souhami","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0135","series-title":"High-Dose Cancer Chemotherapy. Pharmacology, Hematopoietins, Stem Cells","first-page":"719","article-title":"High-dose chemotherapy with autologous bone marrow support for lung cancer","author":"Spitzer","year":"1992"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.1995.13.1.148","article-title":"Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood","volume":"13","author":"Pettengell","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJM199312163292504","article-title":"Initial chemotherapeutic doses and survival in patients with limited small cell lung cancer","volume":"329","author":"Arriagada","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0150","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.88.18.8039","article-title":"Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy","volume":"88","author":"Huber","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0155","first-page":"962","article-title":"In vitro and in vivo targeting of gene expression to melanoma cells","volume":"53","author":"Vile","year":"1993","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0160","first-page":"3860","article-title":"Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection","volume":"53","author":"Vile","year":"1993","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0165","first-page":"230","article-title":"The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice","volume":"8","author":"Greenburg","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0170","first-page":"2055","article-title":"Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: An effective in vitro drug sensitization system","volume":"54","author":"Smythe","year":"1994","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0175","first-page":"5274","article-title":"The \u2018bystander effect\u2019: Tumor regression when a fraction of the tumor mass is genetically modified","volume":"53","author":"Freeman","year":"1993","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0180","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1164\/ajrccm\/137.4.939","article-title":"Localization of surfactant protein synthesis in human lung by in situ hybridization","volume":"137","author":"Phelps","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ajcp\/97.2.233","article-title":"Peripheral airway cell marker expression in non-small cell lung carcinoma","volume":"97","author":"Linnoila","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajcp\/93.1.20","article-title":"Clinicopathologic and immunohistochemical characteristics of bronchial gland cell type adenocarcinoma of the lung","volume":"93","author":"Hirata","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/317361a0","article-title":"Isolation and characterization of the human pulmonary surfactant apoprotein gene","volume":"317","author":"White","year":"1985","journal-title":"Nature"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0200","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1165\/ajrcmb\/6.4.446","article-title":"Characterization of a second human pulmonary surfactant-associated protein SP-A gene","volume":"6","author":"Katyal","year":"1992","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/hum.1994.5.1-29","article-title":"Surfactant protein A-directed toxin gene kills lung cancer cells in vitro","volume":"5","author":"Smith","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0210","doi-asserted-by":"crossref","first-page":"11277","DOI":"10.1073\/pnas.89.23.11277","article-title":"Aerosol gene delivery in vivo","volume":"89","author":"Stribling","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0215","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/nar\/20.12.3233","article-title":"Expression of the human cystic fibrosis transmembrane conductance-regulator gene in the mouse lung after in vivo intratracheal plasmamediated gene transfer","volume":"20","author":"Yoshimura","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0220","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/362250a0","article-title":"Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy","volume":"362","author":"Hyde","year":"1993","journal-title":"Nature"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ng1093-135","article-title":"Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice","volume":"5","author":"Alton","year":"1993","journal-title":"Nature Genet"},{"key":"10.1093\/annonc\/6.suppl_1.S73_bb0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/science.7687073","article-title":"Systemic gene expression after intravenous DNA delivery into adult mice","volume":"261","author":"Zhu","year":"1993","journal-title":"Science"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419614596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419614596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/6\/suppl_1\/S73\/6679625\/6-suppl_1-S73.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T14:40:14Z","timestamp":1714574414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419614596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":35,"alternative-id":["S0923753419614596"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/6.suppl_1.s73","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1995]]}}}